Press Release
News
Press Release
News
Home News
Press Release
COMPANY NEWS
Ascentage Pharma Announces Acceptance of IND Application by China FDA for Clinical Study of Novel IAP Inhibitor to Treat Hepatitis B Infection
Ascentage Pharma Announces Acceptance of IND Application by China FDA for Clinical Study of Novel IAP Inhibitor to Treat Hepatitis B Infection

APG-1387’s apoptosis mechanism shown to be potentially curative in preclinical studiesFirst apoptosis-targeted IAP inhibitor against HBV being pursued in ChinaROCKVILLE, MD and HONG KONG, CHINA—January 8, 2018—Ascentage Pharma, a…